STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2020

The following is a summary of transactions pertaining to restricted stock:

	Shares			Weighted Average Grant Date Fair Value Per Share
Nonvested restricted stock outstanding at December 31, 2019		595,436		$	3.15
Granted		1,191,262			2.49
Canceled		-			-
Vested		(158,858	)		3.17

Nonvested restricted stock outstanding at March 31, 2020		1,627,840			2.67

The following is a summary of transactions pertaining to stock options:

	Shares		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2019		116,000	$	10.56	1.83 years	$	-
Granted/Canceled/Vested		-		-			-

Outstanding at March 31, 2020		116,000		10.56	1.58 years		-

Vested as of March 31, 2020		116,000		10.56	1.58 years		-

Exercisable as of March 31, 2020		116,000		10.56	1.58 years		-

The following table presents a summary of stock options outstanding:

		At March 31, 2020
		Stock Options Outstanding						Stock Options Exercisable
	Exercise Prices	Shares		Contractual Weighted Average Life (years)		Weighted Average Price		Shares		Weighted Average Exercise Price
$	7.79		91,000		1.92	$	7.79		91,000		7.79
$	20.62		25,000		0.35		20.62		25,999		20.62

			116,000		1.58		10.56		116,999		10.56